Updated hourlyHourly refreshTue, Sep 8, 2026
Press Release Database
Recent press releases, indexed by topic.
Healthcare
Austin, Texas--(Newsfile Corp. - September 1, 2026) - As the weight of stress, emotional overwhelm, and pervasive uncertainty continue to impact everyday life, Dr. Celeste Birkhofer's Beyond Quick Fixes: Essential Ingredients for Better Mental Health and a Fulfilling Life (Greenleaf Book Group Press, Sept 1, 2026, $23.95) provides a timely, research-informed guide to help move beyond reactive, superficial remedies to cultivate meaningful transformation and resilience. This book serves as a...
Sep 1 · 12:00·mlpr-newsfile
Healthcare
Vancouver, British Columbia--(Newsfile Corp. - September 1, 2026) - Apptly Health Technologies Corp. (CSE: APPT) (FSE: 4KL) (the "Company" or "Apptly"), operator of the UberDoc direct-pay healthcare marketplace, today announced a strategic partnership with Koning Corporation ("Koning"), manufacturer of the FDA-approved Koning Vera Breast CT.Highlights:FDA-Approved Breast CT: The Koning Vera Breast CT is the only breast CT system with FDA premarket approval for diagnostic imaging of the breast....
Sep 1 · 12:00·mlpr-newsfile
AI · Healthcare
ChatGPT can now connect to trusted healthcare data, helping clinicians securely access patient context, medical research, and more.
Sep 1 · 12:00·mlpr-openai
SaaS · Healthcare
Ten-year Partnership Combines Loamara’s Product Development Expertise With myRocky’s Clinical Platform and Experience Supporting More Than 400,000 Patients TORONTO, ONTARIO - September 1, 2026 ( NEWMEDIAWIRE ) - Loamara Co. , the wellness company behind Green Monke, today announced a ten-year strategic partnership with Rocky Health Inc. (“myRocky”), a leading Health Canada approved digital health platform, to launch Loamara Wellness, a new product line focused on longevity, nutrition and proactive health. The first products will focus on supporting people using GLP 1 medications, alongside protein rich powders designed to support broader nutrition and wellness needs. Additional capsule, powder and gummy formats are expected to follow. The companies are targeting a commercial launch through
Sep 1 · 12:00·NewMediaWire
SaaS · Healthcare
Bridging the gap between ICHRA and Medicare: Two industry leaders combine tax-free health allowances and zero-cost advocacy to combat rising healthcare costs for the aging workforce. The Problem: Standard ICHRA platforms lack Medicare integration, leaving aging workers to navigate complex...
Sep 1 · 12:00·mlpr-prnewswire-wire
Finance · Healthcare
Littleton, Colorado--(Newsfile Corp. - September 1, 2026) - Vivos Therapeutics, Inc. (NASDAQ: VVOS) ("Vivos" or the "Company"), a leading medical technology and healthcare services company focused on the diagnosis and treatment of obstructive sleep apnea (OSA) and related breathing and sleep disorders, today announced that Founder and Chief Executive Officer R. Kirk Huntsman will present at the 2026 Moody Capital Solutions Disruptive Growth & Life Sciences Conference, taking place September 9...
Sep 1 · 12:00·mlpr-newsfile
Finance · Healthcare
GAITHERSBURG, Md., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced a contract modification valued at approximately $24 million from the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS), to supply CYFENDUS ® (Anthrax Vaccine Adsorbed, Adjuvanted) for anthrax preparedness efforts. Anthrax remains a significant global biological threat due to its potential use in a bioterrorism event and its implications for public health and national security.
Sep 1 · 11:55·GlobeNewswire
Finance · Healthcare
ARLINGTON, Mass., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Kala Bio, Inc. (Nasdaq: KALA) ("Kala") and Virotek Inc. ("Virotek"), a CLIA-registered precision health and clinical genomics company, today announced that they have entered into a letter of intent (the "LOI") outlining the principal terms under which the companies intend to negotiate a definitive agreement appointing Kala as the exclusive distributor and reseller in the United States of Virotek's genetic testing and screening program for ophthalmological indications.
Sep 1 · 11:45·GlobeNewswire
Finance · Healthcare
Vancouver, Canada, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (the “Company”), a clinical-stage biopharmaceutical company advancing non-hallucinogenic psychedelic-derived neuroplastogen for scalable treatment of neuropsychiatric, metabolic, and addiction disorders including Alcohol Use Disorder (“AUD”), announced today the initiation of Phase lla, the next stage of its double-blind, placebo-controlled Phase I/IIa clinical trial evaluating CMND-100 for the treatment of AUD, with six patients enrolled to date. Three participants have been enrolled at Tel Aviv Sourasky Medical Center (TASMC) and three at Hadassah Medical Center in Jerusalem, initiating the first multiple-dose treatment phase of Part C (“phase IIa”) following the successful completion of the tria
Sep 1 · 11:37·GlobeNewswire
Finance · Healthcare
NEW YORK, September 01, 2026--DocGo Inc. (Nasdaq: DCGO) ("DocGo"), a leading provider of technology-enabled mobile health and medical transportation services, announced today that Lee Bienstock, Chief Executive Officer, will participate in 1x1 meetings at the Morgan Stanley 24th Annual Global Healthcare Conference on Wednesday September 16th, and will deliver a fireside presentation at 12:20 PM ET on that day. A webcast of the event will be available on the investor relations section of DocGo’s
Sep 1 · 11:35·mlpr-businesswire
Finance · Healthcare
WALTHAM, Mass., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Ardelyx Inc. (Nasdaq: ARDX), (“Ardelyx” or the “Company”) a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs, today announced its participation in the following investor conferences:
Sep 1 · 11:30·GlobeNewswire
Finance · Healthcare
PALO ALTO, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage, multi-product biopharmaceutical company focused on developing medicines for genetic conditions, today announced that members of its management team will participate in fireside chats at the following healthcare investor conferences:
Sep 1 · 11:30·GlobeNewswire